216 hasil
Menampilkan 1–20 · 1,40 detik · RSS
ESMO Real World Data and Digital Oncology
Scopus
ISSN 2949-8201 · Elsevier · 216 artikel di indeks
-
Artikel Jurnal
Histotype-specific incidence and survival of urothelial carcinoma—an analysis of the German North Rhine-Westphalia Cancer Registry
Background: The aim of this study was to evaluate the incidence and survival of urothelial carcinoma (UC) and non-urothelial tumor types. The primary objective was to define the incidence and survival of pure UC and non-UC tumor types. Materials and methods: Malignant invasive urinary cancers of…
-
Artikel Jurnal
Real-world demographics, clinical characteristics, and testing and treatment patterns in patients with non-small-cell lung cancer and extensive-stage small-cell lung cancer in Belgium: the AIBED study
Background: Real-world evidence is essential to understand the implementation of lung cancer treatments. This study describes the characteristics, testing patterns, and treatment of lung cancer patients in Belgium. Methods: This multicenter study used routinely collected longitudinal electronic…
-
Artikel Jurnal
Digital symptom monitoring and activity tracking in chemoradiation—lessons from the CAM experience
Artificial intelligence (AI) is increasingly being explored as a way to improve supportive care during chemoradiotherapy (CRT). Through our CAM 1.0 and CAM 2.0 studies, we examined how AI-supported remote patient monitoring could be integrated into CRT care, revealing both its potential benefits…
-
Artikel Jurnal
AI for clinical trials in oncology
In this perspective, we summarize recent developments in artificial intelligence (AI) applications for oncology clinical trials, divided into four key areas: (1) AI-driven drug design; (2) trial risk assessment, or predicting whether a novel therapy candidate will be safe and efficacious; (3) trial…
-
Artikel Jurnal
AI assistance in tumor multidisciplinary teams
Multidisciplinary teams (MDTs), the cornerstone of modern cancer care, are facing significant operational inefficiencies. These challenges include the laborious, manual synthesis of unstructured, multimodal patient data for case preparation, which is time-consuming and prone to information…
-
Artikel Jurnal
Real-world comparison of avelumab maintenance versus pembrolizumab at progression after first-line platinum-based chemotherapy in metastatic urothelial cancer
Background: For patients with metastatic urothelial cancer of the bladder (mUCB), the standard of care after first-line (1L) platinum-based chemotherapy has shifted from immune checkpoint inhibitor (ICI) treatment upon progression to maintenance ICI, without a direct comparison between both…
-
Artikel Jurnal
Data resource profile: National Cancer Registry Ireland
Background: National Cancer Registry Ireland (NCRI) is the state agency responsible for collecting and analysing data on all cancer patients to help improve health outcomes in Ireland. Established by the Minister for Health under Statutory Instrument 19/1991, it began collecting data in 1994 from…
-
Artikel Jurnal
Real-world survival benefit of adding durvalumab to chemotherapy in cholangiocarcinoma: a retrospective cohort analysis from a German Comprehensive Cancer Centre
Background: Advanced biliary tract cancers (BTCs) carry a poor prognosis. Gemcitabine/platinum chemotherapy was the first-line standard until TOPAZ-1 and KEYNOTE-966 established immune checkpoint inhibitor-based combinations as a new standard. Real-world data with a chemotherapy-only comparator…
-
Artikel Jurnal
From electronic health records to real-world evidence: Savana Next-Generation Registry digital solution
Background: The secondary use of electronic health records (EHRs) offers a major opportunity to generate real-world evidence (RWE) to complement clinical trials and support regulatory and clinical decision making. However, a large proportion of clinically relevant information remains embedded in…
-
Artikel Jurnal
Feasibility of a prospective real-time monitoring system capturing real-world data from elderly patients with acute myeloid leukemia
Background: Real-world data (RWD) are increasingly applied as external controls in phase II–III clinical trials. However, retrospectively monitored RWD may suffer from limitations, including data availability and quality. Prospective monitoring of RWD may potentially overcome such limitations. We…
-
Artikel Jurnal
Mapping population-based cancer registries in Europe: coverage, data availability, and capacity for real-world data generation
Background: Population-based cancer registries (PBCRs) are essential for cancer surveillance and control yet their capacity and coverage vary across Europe. This study presents the first descriptive results of a survey mapping European PBCRs, with a particular focus on registry coverage, data…
-
Artikel Jurnal
Real-world outcomes in patients with advanced epithelial ovarian cancer receiving niraparib as first-line maintenance: a European retrospective cohort study
Background: In this real-world study, outcomes were evaluated in patients with stage III advanced epithelial ovarian cancer (EOC) with no visible residual disease (NVRD) after primary cytoreductive surgery (PCS), a subgroup excluded from the phase III PRIMA trial. Materials and methods: The…
-
Artikel Jurnal
Tumor data extraction from unstructured medical reports: application of an artificial intelligence-enhanced tool in the Eastern Switzerland Cancer Registry
Background: Population-based cancer registries rely heavily on the manual coding of unstructured medical reports, a process that is both time-consuming and resource-intensive. The number of cases and reports is increasing and simultaneously qualified coding personnel are rare, making it challenging…
-
Artikel Jurnal
Understanding return to work after breast cancer through real-world data linkage framework: a Luxembourg digital oncology use case
Background: Breast cancer (BC) has a substantial impact on women of working age, making return to work (RTW) a critical outcome to evaluate. Research on RTW relies on individual-level real-world data integrating clinical and occupational information. Luxembourg offers a unique setting for such…
-
Artikel Jurnal
X-CART: a multimodal real-world data pipeline for explainable AI-driven patient navigation in radiation oncology
Background: Multimodal explainable artificial intelligence (XAI) is transforming oncology, yet its clinical adoption is constrained by limited interpretability and fragmented use of real-world data (RWD), including electronic medical records, geospatial data, and social determinants of health. We…
-
Artikel Jurnal
Prospective, longitudinal oncology registries enabling advanced real-world evidence: the iOMEDICO experience
Background: Randomized controlled trials (RCTs) remain the gold standard for evidence on treatment efficacy but face limitations: restrictive eligibility criteria exclude real-world populations, head-to-head comparisons between approved regimens are rare, and absolute effectiveness in unselected…
-
Artikel Jurnal
Semi-automated monitoring of deviations from historical incidence trends for enhanced timeliness in cancer control
Background: Population-based cancer registries aim for timely reporting of cancer incidence and rapid identification of unexpected patterns to support cancer control. To facilitate large-scale, systematic, first evaluation of incidence data, a semi-automated tool was built that flags statistically…
-
Artikel Jurnal
Applying clinical natural language processing to lung cancer in Spain: a terminology-based panel approach
Background: We present a novel methodological framework for developing and validating a terminology-based Disease Panel to identify and characterize patients with metastatic non-small-cell lung cancer (mNSCLC) in a Spanish cohort by applying clinical natural language processing (cNLP) to electronic…
-
Artikel Jurnal
Impact of concomitant proton pump inhibitors in patients treated for advanced or metastatic NSCLC: a target trial emulation protocol
Background: Proton pump inhibitors (PPIs) are commonly coprescribed in patients with advanced or metastatic non-small-cell lung cancer (NSCLC), including those treated with tyrosine kinase inhibitors (TKIs) or immune checkpoint inhibitors (ICIs), often without a well-defined indication. PPIs may…
-
Artikel Jurnal
Real-world evidence for the postmarket surveillance of cancer medicines: opportunities and challenges using Australia’s population-based cancer registries
Spending on cancer medicines has increased rapidly worldwide, driven by the introduction of immunotherapy and targeted therapy. Australia exemplifies this trend, with cancer medicines representing one of the largest and fastest-growing areas of expenditure for Australia’s public medicines funder…